Kidney story: the beat sheet
One narrator, first person, a reader who was told to wait. Written from the teardowns of the kidney pages David kept. It is the order our page CS-P2 follows, angle CS-A03.
What this family does
Every kept kidney story makes the same argument in the same order. The reader did everything right and her numbers still moved. Her doctor gave her a plan with nothing in it to do. The cause was never her effort: the wear starts inside the cell, where her water, her diet and her vitamins do not reach. One nutrient does reach it. Here is how to tell a good one from a bad one, and here is the one that passed.
The product is the last third of the argument, not the first. On the strongest page the ingredient is named at 45% and the brand at 61%. The reader is taught to want the nutrient before she is told who sells it.
The three doors (one body, three headlines)
The store runs one kidney story under three headlines and changes nothing else. Each headline is cut from a different beat of the same body.
| Door | The headline is built on | The feeling | It promises | Our read |
|---|---|---|---|---|
| Dismissal | the sentence her doctor said to her | brushed off | a cause | strongest: it is a sentence the reader has really heard, and the body pays it off in order |
| Discovery | her effort, then a thing teased by its color | unfairness | an object | second: the best curiosity, but it gives away that the answer is a substance |
| Silent slide | no symptoms, months lost | fear and regret | an explanation | weakest: fear with nothing to do, and the body later lifts the blame the headline lays |
CS-P2 takes the dismissal door. It is also our own angle's hook, written before the swipe.
The order
Shares are of the page's words. "Ours" is what stands in that place on CS-P2, with the Truth-Gate ids it rests on.
| # | Beat | Share | What it does to the reader | Lever | Ours |
|---|---|---|---|---|---|
| 1 | Headline | 1% | She hears her own doctor's words, and a person who did something about them | mirroring, curiosity | the doctor's two words about her kidney numbers, then what she did (r10) |
| 2 | Disclosure | 1% | She knows who is speaking before any claim | candor | sponsored, and the narrator is a composite of readers |
| 3 | The routine test | 3% | She is in the room: a result with no warning | story, identification | a yearly panel, a number that had drifted, a body that felt fine |
| 4 | The clean record | 5% | "That is me": she did everything right | mirroring | the walks, the water, the salt, and the dread before each result |
| 5 | The shrug | 2% | The plan has nothing in it to do. The doctor stays an ally | common enemy: the wait | "watch it", a re-test in six months |
| 6 | The ledger | 5% | Each fix, what it cost her, what did not move | specificity | water, salt, the multivitamin, the supplement aisle. No figures |
| 7 | The turn | 4% | She stops reading opinions and starts reading research | open loop | one night, the studies instead of the forums |
| 8 | The hidden cause | 5% | The wear has a name and a place | reason why | unstable oxygen molecules, the kidneys' smallest vessels (r1, m5) |
| 9 | The record | 3% | It is not her idea. It is in the literature | borrowed authority | PubMed 17444279, the aging kidney and oxidative stress |
| 10 | The open inside | 8% | Why nothing she took could work | new idea, reason why | vitamin C outside the cell, vitamin E on its surface, the inside left open. Water-soluble pills leave through the kidneys (p3, r5, r26). The idea is shown with one household picture and is never given a coined name |
| 11 | The ledger, re-read | 4% | Every failed fix is explained. The blame lifts | vindication | it was never her effort. It was reach |
| 12 | The criteria | 3% | She knows what the answer must do before she meets it | commitment | reach the cell, cover the whole cell wall, add no work for the kidneys |
| 13 | The nutrient | 5% | The answer arrives as the thing that meets the criteria | loop closed | astaxanthin, the red pigment of microalgae. It spans the cell wall: The Cell Shield (m2, r15) |
| 14 | The count | 3% | It is studied, not fringe | borrowed authority | 60+ clinical studies, 6,000 times vitamin C (r14, m3) |
| 15 | The worry | 4% | Her real fear is answered: one more pill for the kidneys to handle | objection | fat-soluble, taken into the cell, less for the kidneys than a multivitamin. She asks her doctor (r26) |
| 16 | The label tests | 6% | She can tell a good one from a bad one | contrast | 12 mg in one softgel, natural not synthetic, every batch third-party lab tested (b7, c4, r16, c1, c3) |
| 17 | The name | 2% | The brand is the one that passed her tests | relief | CellScience Astaxanthin, at about 58% of the page |
| 18 | The guarantee, in the story | 2% | The reason she dared | risk reversal | the 30-Day Money-Back Guarantee, keep the bag |
| 19 | The honest weeks | 8% | She is told the first days feel like nothing, then what came | candor, specificity | steadier afternoons first, small print easier, a calmer stomach later. One line from someone who lives with her (r7, b6, r8) |
| 20 | Not a medicine | 3% | The page says what it is not | candor | she keeps her appointments and tells her doctor what she takes (r27) |
| 21 | The next test | 3% | The scene she dreads, replayed without the dread | future pacing | she walks in steady. No figure and no result is given: the doctor sets the next date and they keep watching |
| 22 | Two roads, then the steps | 6% | The choice is made small and the path is laid out | commitment, ease | keep watching, or watch and protect. Order, one softgel with a meal, a note on day one, read back in week four, one email before day thirty (b9, r31) |
| 23 | The quiz | 4% | Three small yeses, then her own reasons read back to her | commitment | the 3-step quiz, the PDP's own saving |
| 24 | P.S. | 3% | The last doubt: why did my doctor never say this | objection | a doctor watches and prescribes. A softgel is neither. Bring the label to the next visit |
Proportion and rhythm
- Story, cause and first proof take the first 45%. The nutrient comes at 45%, the brand near 58%.
- The blame lifts just before the answer appears. On the strongest page that is at 40%.
- Failed fixes are told twice: once as effort, once explained by the cause. The second telling is what makes the reader's own history the evidence.
- Results are feelings a reader can check on herself. The strongest pages still lean on a lab figure at the end. Ours does not.
- On a phone: a picture or a heading at least every 200 words.
Take
- The sentence the reader was really told, as the headline.
- The doctor as an ally. The villain is the wait.
- Criteria before the nutrient, the nutrient before the brand.
- The ledger, then the ledger re-read.
- The guarantee inside the story, and again as a task with a date.
- The first days feel like nothing, said before the first result.
- A witness who lives with her.
- The P.S. that answers why the doctor never said it.
Leave
- Every sentence of theirs. The teardowns describe their lines. Our lines are written from the beats.
- Lab figures, stage labels, disease words, and any promise about a test result.
- The "verified" badge on an unverifiable person, the unnamed researcher, the forum screenshots.
- The invented shortage, the dated stock update, the offer only for visitors of this page.
- The industry-hides-it story, and any picture of a group of people as the enemy.
- The carrier-oil argument. It is banned for us.
- A 90-day window. Ours is the 30-Day Money-Back Guarantee.
Rules for our page
- The narrator is a composite and the page says so before the first claim.
- No number from a lab sheet, ours or hers, and no lab result of any kind from the narrator. The research holds no kidney study.
- The narrator's doctor never clears the softgel and never credits it. She reads the label, adds it to the list, and keeps the date.
- The dated task sits inside the refund window: a refund is asked for within 30 days of delivery, so the second look is in week four.
- The batch proof is “third-party lab tested”. The code on the bag is out (David, 2026-09-15).
- The in-article picture is the plain pack. A picture with claims set into it is refused by the builder.
- The Cell Shield is named only after the idea it names is on the page.
- Every row of the page names its beat and the Truth-Gate ids under it. The builder refuses a row without them.
The pages David kept
| Page | Type | Narrator | House chief | Product named at | Big idea |
|---|---|---|---|---|---|
| Renal Reset Journal – Native Bloom getelavyn.com · twin of nativebloom--adv-k-nativebloom | F2 | doctor | 7/10 | 42% | Kidney numbers keep sliding because every treatment polices what goes into the body while nobody clears the clogged drainage on the way out, and the industry paid to manage the slide has no reason to say so. |
| Renal Reset Journal – Native Bloom trynativebloom.com | F2 | doctor | 7/10 | 42% | Kidney numbers keep sliding because every treatment polices what goes into the body while nobody clears the clogged drainage on the way out, and the industry paid to manage the slide has no reason to say so. |
| Top Kidney Researcher: I Found The Reason Why Your eGFR Keeps Declinin – Rovina tryrovina.com | F2 | researcher as billed; in practice a first-person customer who turns founder | 6/10 | 63% | The falling score, the swelling and the tiredness are one problem, oxidation of the membranes of the kidney's filter cells, which blood pressure medication was never aimed at and which only a membrane-spanning antioxidant of the right dose and form can reach. |
| I Did Everything Right For My Kidneys. My Numbers Still Slipped. Then – Rovina tryrovina.com · twin of rovina--what-was-wearing-my-kidneys-down | F2 | first-person customer | 8/10 | 61% | Her effort never failed for lack of discipline: food, water and ordinary antioxidants work outside the cell or on one side of its wall, the wear builds up inside, and one red algae pigment is shaped to sit across both sides. |
| My Doctor Just Said "We'll Monitor It." So I Read the Studies He Never – Rovina tryrovina.com | F2 | first-person customer | 8/10 | 61% | Her effort never failed for lack of discipline: food, water and ordinary antioxidants work outside the cell or on one side of its wall, the wear builds up inside, and one red algae pigment is shaped to sit across both sides. |
| My Kidneys Were Quietly Slipping While I Felt Completely Fine. By the – Rovina tryrovina.com · twin of rovina--what-was-wearing-my-kidneys-down | F2 | first-person customer | 7/10 | 61% | Her effort never failed for lack of discipline: food, water and ordinary antioxidants work outside the cell or on one side of its wall, the wear builds up inside, and one red algae pigment is shaped to sit across both sides. |
| Astaxanthin and Your Kidneys: The Antioxidant Most Miss tryrovina.com | F1 | first-person customer | 6/10 | 60.7% | The page argues that the kidneys labour without rest or help, that the tiredness, puffiness and fog people past fifty blame on age are the cost of that neglect, and that one red softgel a day supplies the missing help. |
| Top 5 Astaxanthin Supplements for Kidney Support in 2026 – Clarity MD claritymd.co · twin of claritymd--top-5-astaxanthin-supplements-of-2026-vstd-282 | F4 | editor | 6/10 | 16% | For a reader watching their kidney numbers: the ingredient is sound, most bottles fail to deliver it to the organs, and one product passes the three label checks. |
| Top 5 Kidney Support Supplements of 2026 – Clarity MD claritymd.co · twin of claritymd--top-5-astaxanthin-supplements-of-2026-vstd-282 | F4 | editor | 5/10 | 16% | Most kidney supplements do nothing; one researched antioxidant does, and a single bottle of it passes every check. |
The numbers under the sheet
Across this family's teardowns: where each beat first appears, how much of the page it takes, and the levers it pulls.
| First at | Beat | Pages | Share of words | Levers |
|---|---|---|---|---|
| -0.0% | page-furniture | 9/9 | 0.6% | noneurgencyborrowed-authorityexclusivity |
| 0.7% | hook-headline | 9/9 | 0.8% | curiosity-gapspecificityidentificationearned-authority |
| 1.4% | deck | 6/9 | 1.1% | earned-authorityspecificityopen-loophope |
| 2.0% | image | 9/9 | 0.1% | story-transportspecificitypattern-interruptmirroring |
| 3.7% | authority-stamp | 9/9 | 0.5% | specificitysocial-proofearned-authorityidentification |
| 4.1% | proof-expert | 1/9 | 5.2% | borrowed-authorityloss-aversionsocial-proofcandor |
| 5.3% | cold-open-scene | 6/9 | 3.0% | identificationcandorstory-transportfear-of-decline |
| 7.2% | symptom-mirror | 9/9 | 3.9% | mirroringidentificationspecificityrelief |
| 11.1% | ranking-criteria | 2/9 | 3.3% | specificityreason-whycontrastanchoring |
| 11.2% | failed-solutions | 9/9 | 4.1% | contrastspecificityreason-whyidentification |
| 11.5% | dismissal-by-authority | 6/9 | 2.2% | common-enemycontrastvindicationmirroring |
| 15.7% | ranked-entry | 2/9 | 55.3% | candorcontrastanchoringreason-why |
| 15.9% | turning-point | 9/9 | 3.7% | open-loopstory-transportspecificityearned-authority |
| 18.4% | villain-reveal | 9/9 | 3.8% | reason-whycommon-enemyvindicationnew-mechanism |
| 19.9% | mechanism | 7/9 | 11.5% | reason-whynew-mechanismspecificityloop-closed |
| 22.0% | proof-social | 9/9 | 6.7% | social-proofspecificityconsensusstory-transport |
| 26.5% | proof-study | 9/9 | 4.3% | borrowed-authorityspecificitynew-mechanismreason-why |
| 35.4% | objection | 7/9 | 5.0% | objection-preemptidentificationmirroringreason-why |
| 36.6% | disclosure | 6/9 | 5.1% | candornoneborrowed-authorityobjection-preempt |
| 38.6% | differentiation | 9/9 | 6.5% | contrastreason-whyspecificityborrowed-authority |
| 49.5% | results-timeline | 7/9 | 8.0% | specificityreliefcandorhope |
| 60.0% | product-reveal | 7/9 | 1.8% | reason-whyloop-closedearned-authorityidentification |
| 61.0% | offer | 8/9 | 4.4% | anchoringopen-loopurgencyease |
| 71.5% | guarantee | 9/9 | 3.2% | risk-reversaleasespecificitycommitment |
| 74.5% | stakes | 9/9 | 1.4% | loss-aversionfear-of-declinespecificitystory-transport |
| 75.8% | future-pace | 7/9 | 4.0% | future-pacingreliefhopevindication |
| 80.1% | close | 9/9 | 4.3% | commitmentcontrastidentificationloop-closed |
| 80.4% | urgency | 7/9 | 4.2% | urgencyscarcityexclusivityreason-why |
| 80.7% | cta | 9/9 | 0.8% | commitmenteaserisk-reversalurgency |
| 85.7% | how-to-use | 4/9 | 1.2% | easespecificityfuture-pacing |
| 91.1% | comments | 2/9 | 12.3% | social-proofobjection-preemptmirroringvindication |